SP600125: Selective ATP-Competitive JNK Inhibitor for MAP...
2026-01-20
SP600125 is a highly selective, ATP-competitive c-Jun N-terminal kinase (JNK) inhibitor used in apoptosis, inflammation, and cancer research. The compound exhibits nanomolar potency and high kinase selectivity, making it a robust tool for dissecting JNK signaling. Its well-characterized activity profile supports reproducible modulation of cytokine expression and MAPK pathway inhibition.